Navigation Links
Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argos's Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
Date:5/3/2012

DURHAM, N.C., May 3, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that study results demonstrated that analytical treatment interruption to assess the antiviral activity of Argos's Arcelis™ personalized immunotherapy for the treatment of HIV patients, AGS-004, is an acceptable strategy for at least 16 weeks. Study results were published in the Journal of Medical Virology (84:885–889, 2012).

"Establishing the safety of analytical treatment interruptions of at least 16 weeks is an important step forward in assessing the impact of immunotherapy on viral load control," said Charles Nicolette, Ph.D., chief scientific officer and vice president of research and development of Argos. "Therapeutic vaccines such as AGS-004 have the potential to decrease long-term antiretroviral therapy which has limitations such as drug toxicity, the risk of developing resistance and others. We look forward to advancing our Phase 2b trial of AGS-004 to further demonstrate its efficacy and safety for the treatment of HIV patients."

The potential risks of short-term interruption of antiretroviral therapy in the AGS-004-001 study were assessed in a retrospective subgroup study analyzing data from patients in the strategies for management of anti-retroviral therapy (SMART) study with matched eligibility criteria. The subgroup analysis included 440 of 2,720 on the drug conservation (DC) arm and 436 of 2,752 on the viral suppression (VS) arm that matched the AGS-004-001 inclusion criteria and were used in the SMART subgroup analysis. In the first 16 weeks following randomization into the SMART study there were no deaths in either subgroup.  There were two AIDS-related events in the DC subgroup and one in the VS subgroup, making the overall risk of AIDS related events two per 100 person years (0.005%) and one per 100 person years (0.002%) in the two subgroups, respectively.  There were
'/>"/>

SOURCE Argos Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 Stryker Orthopaedics, the Official Joint ... is rounding out its debut year of the relationship ... Scottsdale, AZ. This marks the eleventh tournament ... that the brand has activated on-site with the "Stryker ... fans on the importance of joint health.  ...
(Date:10/30/2014)... , Oct. 30, 2014 WuXi PharmaTech (Cayman) Inc. ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... office in the Tel Aviv ... will promote WuXi,s broad platform of integrated R&D services ...
(Date:10/30/2014)... -- Boston Scientific Corporation (NYSE: BSX ) ... Annual Healthcare Conference on Tuesday, November 11, 2014 in ... , executive vice president and chief financial officer, will ... 8:00 a.m. PT followed by a question and answer ... and question and answer session will be available to ...
Breaking Medicine Technology:Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2
... March 20 Optimum Health Regeneration,Center announced the ... management and impaired mobility. This New Mexico family, ... significant improvements in reduced pain,increased physical mobility and ... umbilical cord stem cells and ozone therapy at ...
... IDM Pharma, Inc.,(the Company) (Nasdaq: IDMI ... a clinical protocol finalized with the U.S. Food ... eligible,high-risk osteosarcoma patients through a compassionate access study., ... the increasing number of,requests for compassionate access to ...
Cached Medicine Technology:Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico 2IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 2IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 3IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 4IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 5
(Date:10/31/2014)... Adults 65 and older who ... coverage during the current open enrollment period can ... step-by-step guidance, the company announced today. , The ... the correct Medicare Advantage plan, understanding the differences ... , “With just one month remaining of open ...
(Date:10/31/2014)... News) -- Carving pumpkins and trick-or-treating may seem like ... emergency rooms in the United States every year, experts ... fifth highest number of ER visits involving children aged ... the National Electronic Injury Surveillance System. Nearly ... the American Academy of Orthopaedic Surgeons and the Pediatric ...
(Date:10/31/2014)... Dennis Thompson ... News) -- A full-court press involving all public health ... to quell the current West African epidemic, a new ... the Ebola-infected dead in a hygienic way, immediately isolating ... and providing better protection for health care workers -- ...
(Date:10/31/2014)... Institutes of Health will facilitate communication among scientists, ... research, from diagnosis to treatment. The Research Domain ... National Institute of Mental Health (NIMH), part of ... RDoC initiative. , The aim of the ... research that translates basic science into clinical settings ...
(Date:10/31/2014)... (HealthDay News) -- There are clear differences in the ... brains of healthy people, new research indicates. ... findings could help doctors diagnose this baffling condition and ... fatigue syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains ...
Breaking Medicine News(10 mins):Health News:Halloween at the ER Is No Treat 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 3Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 3
... and Author Honored for Worldwide Contribution to Medicine , ... is pleased to announce that world-renown laparoscopic surgeon Constantine Frantzides, ... has been selected as one of America,s Top Doctors ... the ninth annual Castle Connolly acclaimed guide to the top ...
... , , , , ... WESTPORT, Conn. , Jan. 23 Save the Children and ... affected by the earthquake. Westport -based Save the Children,s emergency response ... medical supplies in the town of Leogane and at the general hospital ...
... While genes matter, teacher/parent input is key, researchers find ... an important role in the growth of young children,s ... have to take more seriously genetic influences on learning, ... skills can make strides with proper instruction," lead author ...
... Experts find physical and mental benefits as people grow old ... military campaigns and gunning down bad guys might not sound ... or exercise. , But they might want to start, some ... video games have the potential to help seniors age more ...
... at St. Joseph,s Hospital and Medical Center have been awarded ... (NIH) to research the effects of nicotine and develop new ... research projects at the Phoenix-based institute in the next several ... Research at Barrow, is one of the world,s leading experts ...
... the medical university Karolinska Institutet have created a genetically ... by blue light. Shining blue light on brainstems or ... activity. The findings, which are published in the scientific ... to the recovery of walking after spinal cord injury. ...
Cached Medicine News:Health News:Dr. Constantine Frantzides Named One of America's Top Doctors 2Health News:Save the Children Partners with AmeriCares to Treat More than 85,000 Haitians 2Health News:Save the Children Partners with AmeriCares to Treat More than 85,000 Haitians 3Health News:Save the Children Partners with AmeriCares to Treat More than 85,000 Haitians 4Health News:Environment Crucial to Boosting Child's Reading Skills 2Health News:Video Gaming Just Might Fight Aging 2Health News:Video Gaming Just Might Fight Aging 3Health News:Scientists shed new light on walking 2
... Liters of pure water, Complete, Compact Systems ... Water,Millipores compact S.D.S. Storage and Distribution Systems ... liters of purified water produced by Elix ... purity of stored water, provide effective protection ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: